Dld Asset Management, LP Axsome Therapeutics, Inc. Call Options Transaction History

Dld Asset Management, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $118,500 - $206,950	-5,000 Reduced 16.67%	25,000 $1.03 Million
Q4 2021 Feb 22, 2022	SELL	$30.7 - $43.36 $91.2 Million - $129 Million	-2,970,000 Reduced 99.0%	30,000 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $92.1 Million - $130 Million	3,000,000 New	3,000,000 $1.13 Million
Q1 2020 May 14, 2020	SELL	$41.2 - $101.31 $535,600 - $1.32 Million	-13,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $217,230 - $1.38 Million	13,000 New	13,000 $1.34 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.